HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C J Harrison Selected Research
C J Harrison Research Topics
Disease
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2010 - 02/2000
4
Infections
10/2009 - 02/2000
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2018 - 02/2000
2
Herpes Genitalis (Genital Herpes)
03/2002 - 03/2001
2
Otitis Media
11/2001 - 10/2001
2
Chromosome Aberrations (Chromosome Abnormalities)
09/2001 - 09/2000
1
Melanoma (Melanoma, Malignant)
03/2022
1
Leukemia
01/2017
1
Breast Neoplasms (Breast Cancer)
09/2015
1
Cardiotoxicity
12/2005
1
Multiple Myeloma
09/2005
1
Pathologic Complete Response
01/2004
1
Warts (Wart)
03/2002
1
Virus Diseases (Viral Diseases)
03/2002
1
Otitis
11/2001
1
Cytomegalovirus Infections (Inclusion Disease)
06/2001
1
Exanthema (Rash)
01/2001
1
Diarrhea
01/2001
1
Fever (Fevers)
01/2001
1
Appendicitis
01/2001
1
Down Syndrome (Down's Syndrome)
02/2000
1
Human Influenza (Influenza)
01/2000
Drug/Important Bio-Agent (IBA)
4
Anti-Bacterial Agents (Antibiotics)
IBA
01/2004 - 01/2001
3
Imiquimod (Aldara)
FDA Link
Generic
03/2002 - 02/2001
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 09/2015
2
Glycoproteins (Glycoprotein)
IBA
06/2001 - 02/2001
2
Antiviral Agents (Antivirals)
IBA
03/2001 - 01/2000
1
Proteome
IBA
01/2018
1
1- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)urea
IBA
01/2017
1
Aurora Kinases
IBA
01/2017
1
Transcription Factors (Transcription Factor)
IBA
09/2015
1
Virulence Factors (Pathogenicity Factors)
IBA
10/2009
1
Cytarabine (Cytosar-U)
FDA Link
Generic
12/2005
1
Anthracyclines
IBA
12/2005
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
09/2005
1
Amoxicillin (Wymox)
FDA Link
Generic
11/2001
1
Clavulanic Acid (Potassium Clavulanate)
FDA Link
Generic
11/2001
1
Penicillins (Penicillin)
FDA Link
10/2001
1
resiquimod
IBA
03/2001
1
Vaccines
IBA
02/2001
1
Meropenem (Merrem)
FDA Link
Generic
01/2001
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2000
1
Dacarbazine (DIC)
FDA Link
Generic
02/2000
Therapy/Procedure
5
Therapeutics
01/2004 - 09/2000
1
Radiotherapy
03/2022
1
Aftercare (After-Treatment)
03/2022
1
Ligation
12/2010
1
Immunomodulation
03/2002
1
Antibiotic Prophylaxis
10/2001
1
Chemoprevention
10/2001